Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETINGS03-04-2023
03-04-2023
Eris Lifesciences Ltd - 540596 - Closure of Trading Window
INTIMATION OF CLOSURE OF TRADING WINDOW29-03-2023
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETINGS.27-03-2023
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
We refer to our earlier intimations dated 16th March, 2023 for acquisition of nine cosmetic dermatology brands from Dr.Reddy''s Laboratories Ltd. and 21st March, 2023 for updation of the deal completion date24-03-2023
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
TRANSCRIPT OF CONFERENCE CALLSCHEDULED IN CONNECTION WITH THE ACQUISITION OF NINE DERMATOLOGY BRANDS FROM DR.REDDY'S LABORATORIES LTD23-03-2023
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
UPDATE ON ACQUISITION We refer to the announcement made on 16th March, 2023, pertaining to the acquisition of a part of the dermatology portfolio of Dr. Reddy''s Laboratories Ltd. by way of acquisition of 9 (Nine) trademarks along with their applicable line Extensions. It is hereby notified that based on the comfort derived from the information, records, documents provided by Dr. Reddy's Laboratories Limited so far the completion has been advanced and is now targeted to happen on or about 24th March, 2023 instead of the previously targeted date of 31st March, 2023.21-03-2023
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING20-03-2023
Buy Eris Lifesciences; target of Rs 780: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 780 in its research report dated March 17, 2023.17-03-2023
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Dear Sir/Madam, This is to inform that the Audio Recording of the Conference Call which was held on Thursday, 16 March 2023 in connection with the acquisition of nine dermatology brands from Dr. Reddy''s Laboratories Ltd., is available on the website of the Company and can be accessed through the following link: Link: https://eris.co.in/announcements-notices/ (File name: Conference call recording)16-03-2023
Eris Lifesciences Call on Brand Acquisitions from Dr. Reddy's
Conference Call with Eris Lifesciences Management and Analysts on the acquisitions of dermatology brands from Dr. Reddy's. Listen to the full earnings transcript.16-03-2023